A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

NCT06520488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: HRS-4642

Sponsor

Jiangsu HengRui Medicine Co., Ltd.